SOURCE: USDM Life Sciences

USDM Life Sciences

May 19, 2014 10:35 ET

Vice President of Unique Device Identification Solutions and Services at USDM Life Sciences, Jay Crowley Will Present at UDI Implementation Workshop

Jay Crowley Is the Architect of FDA's UDI Final Rule

SANTA BARBARA, CA--(Marketwired - May 19, 2014) - USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, is pleased to announce Jay Crowley, Vice President of UDI Solutions and Services, will give a presentation about UDI compliance at the UDI Implementation Workshop in Baltimore, MD. Crowley is scheduled to speak at 12:45 p.m. on Thursday, May 22.

The UDI Implementation Workshop will help the medical device community become compliant with the FDA UDI Final Rule and offer guidance for the Global UDI Database (GUDID). Crowley will explain how to overcome UDI compliance obstacles and moderate a panel discussion about UDI compliance. 

"I look forward to continuing to work with the medical device community to ensure UDI compliance by the UDI Final Rule deadline," said Crowley. "I also want to make sure organizations are taking advantage of all the benefits of the UDI system."  

As Vice President of UDI Solutions and Services at USDM Life Sciences, Crowley helps medical device manufacturers achieve regulatory compliance as well as internal benefits and competitive advantage with UDI implementation. The FDA UDI Final Rule requires that most medical devices distributed in the United States carry a unique device identifier, or UDI.

Crowley held various positions over nearly 27 years at the FDA. Most recently, he was Senior Advisor for Patient Safety, in the FDA's Center for Devices and Radiological Health. Crowley had primary responsibility for the development and implementation of the FDA's UDI system. 

The UDI Implementation Workshop is May 20-22, 2014 at the Hilton Baltimore in Baltimore, MD.

About USDM Life Sciences:
USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries. USDM Life Sciences has more than 14 years of experience supplying our clients in the life science industry with compliance services during each phase of their drug and product development cycle while partnering with best of breed organizations to help companies simplify, unify and optimize their business and compliance objectives. For more information, please visit

Contact Information